232 related articles for article (PubMed ID: 3329302)
1. Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage.
Tettenborn D; Porto L; Ryman T; Strugo V; Taquoi G; Battye R
Neurosurg Rev; 1987; 10(2):77-84. PubMed ID: 3329302
[TBL] [Abstract][Full Text] [Related]
2. Nimodipine in subarachnoid hemorrhage.
DiPalma JR
Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
[TBL] [Abstract][Full Text] [Related]
3. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
5. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
[TBL] [Abstract][Full Text] [Related]
6. Nimodipine treatment of subarachnoid hemorrhage.
Laursen J; Jensen F; Mikkelsen E; Jakobsen P
Clin Neurol Neurosurg; 1988; 90(4):329-37. PubMed ID: 3233859
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
Solar P; Mackerle Z; Joukal M; Jancalek R
Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
[TBL] [Abstract][Full Text] [Related]
10. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
11. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage?
Hernández-Durán S; Mielke D; Rohde V; Malinova V
World Neurosurg; 2019 Dec; 132():e834-e840. PubMed ID: 31404696
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage.
Liu GJ; Luo J; Zhang LP; Wang ZJ; Xu LL; He GH; Zeng YJ; Wang YF
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):834-44. PubMed ID: 21999736
[TBL] [Abstract][Full Text] [Related]
13. [Our experience with using nimodipine in the treatment of ischemic complications after subarachnoid hemorrhage].
Danilewicz B; Czepko R; Zawiliński J; Betlej M
Neurol Neurochir Pol; 1991; 25(2):222-9. PubMed ID: 1922667
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
Desbordes JM; Ades PE; Guggiari M
Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage.
Tettenborn D; Dycka J
Stroke; 1990 Dec; 21(12 Suppl):IV85-9. PubMed ID: 2148037
[No Abstract] [Full Text] [Related]
16. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 2. Pulsatility indices: normal reference values and characteristics in subarachnoid hemorrhage.
Steinmeier R; Laumer R; Bondár I; Priem R; Fahlbusch R
Neurosurgery; 1993 Jul; 33(1):10-8; discussion 18-9. PubMed ID: 8355825
[TBL] [Abstract][Full Text] [Related]
17. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Di Mascio R; Marchioli R; Tognoni G
Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
[TBL] [Abstract][Full Text] [Related]
18. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
Heffren J; McIntosh AM; Reiter PD
Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.
Philippon J; Grob R; Dagreou F; Guggiari M; Rivierez M; Viars P
Acta Neurochir (Wien); 1986; 82(3-4):110-4. PubMed ID: 3538789
[TBL] [Abstract][Full Text] [Related]
20. [Effect of nimodipine on the results of surgical treatment of intracranial aneurysms--preliminary report].
Zawirski M; Wróbel-Wiśniewska G; Jaskólski D
Neurol Neurochir Pol; 1991; 25(3):349-54. PubMed ID: 1961382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
